Trial Profile
Efficacy of TR 987, Beta-1,3-1,6-D-glucan, in the Treatment of Chronic Venous Insufficiency Ulcers: a Two-arm, Double-blind, Placebo-controlled, Randomized Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs TR 987 (Primary)
- Indications Varicose ulcer
- Focus Therapeutic Use
- Sponsors SerenaGroup
- 19 Oct 2020 Planned End Date changed from 1 Nov 2019 to 1 Apr 2021.
- 19 Oct 2020 Status changed from recruiting to active, no longer recruiting.
- 02 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Nov 2019.